| 1 |
Clarification on the submission of applications for grant of Permission to Import and Market New Drugs not approved anywhere in the world, wherein phase III Global Clinical Trials (GCT) are ongoing or completed with participation of Indian subjects under the New Drugs and Clinical Trials Rules, 2019 |
2026-Aug-10 |
|
400 KB |
| 2 |
Vigilance on imported cosmetics products sold in the domestic market without valid lmport Registration certificate |
2026-Jul-23 |
|
255 KB |
| 3 |
Clarification regarding submission of applications under Rule 4 of the Drugs and Cosmetics (Compounding of Offences) Rules, 2025. |
2026-Jul-22 |
|
67 KB |
| 4 |
Inviting comments on consideration of the proposal regarding Issue of use of brand name extensions by the pharmaceutical firms |
2026-Jul-06 |
|
53 KB |
| 5 |
Sale of In-Vitro Fertilization media, reagents and related consumables used in Assisted Reproductive Technology procedures |
2026-Jun-24 |
|
323 KB |
| 6 |
Submission of Post Approval Changes Applications of Registration Certificate and Import Licence of Human Vaccines and Anti-sera through SUGAM Portal |
2026-Jun-24 |
|
477 KB |
| 7 |
Regulation of Formulation intermediates such as Directly Compressible granules, Taste masked granules, Modified release granules / Pellets |
2026-Jun-24 |
|
758 KB |
| 8 |
Constitution of Consultancy Committee of Key Stakeholders for Advice on Suo-Motu Disclosure under Section 4 of the RTI Act, 2005 in CDSCO |
2026-Jun-16 |
|
134 KB |
| 9 |
Submission of Compliance for lmported/manufactured Hair Color Cosmetics Products as per Cosmetics Rules, 2020 and applicable BIS Standards |
2026-Jun-11 |
|
350 KB |
| 10 |
Implementation of Pharmacovigilance (PV) System as per the requirement of Schedule M of Drugs & Cosmetics Act 1940 and the Rules made there under |
2026-Jun-03 |
|
316 KB |
